Emergent Biosolutions

Founded in 1998, Emergent Biosolutions’s history has been one of innovation and growth. It stays true to its mission: to protect and enhance life. 

Emergent is a manufacturer of the only FDA-approved anthrax vaccine, BioThrax, and is a major supplier to the US government. This has enabled the company to expand into other therapeutic areas.

In 2014, Emergent acquired Cangene Corporation, bringing over 70 years of experience in researching and marketing to the company. These new skills gave Emergent a better understanding of lifesaving therapies for treatment of rare diseases, blood disorders, and medical countermeasures for biodefense.

Contact Info

155 Innovation Drive Winnipeg R3T 5Y3 MB Canada
P: 1 204 275 4200




Emergent BioSolutions is currently seeking a Sr Project Engineer for our Engineering Delivery Department at our Winnipeg location. The successful candidate will have completed a Post-Secondary Program in an Engineering Discipline, acā€¦

Read More

12 Month Term Position

Emergent BioSolutions is currently seeking a Sr Specialist for our Regulatory Affairs Department. The successful candidate will have 5 years of Regulatory Affairs experience in pharmaceutical/biological/vaccine product developmentā€¦

Read More

Latest News

Subscribe to the BAM Newsletter

Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.